Evans David Thomas
Chief Financial Officer
Evans David Thomas has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: May 19, 2026.
On the most recent filing, Evans David Thomas is listed as Chief Financial Officer at Cardlytics, Inc. Inside the rolling window, Evans David Thomas reported 2 open-market purchases totaling $129K in CDLX and no open-market sales. The largest disclosed transaction in the window is a purchase of 150,000 CDLX shares on May 15, 2026, worth $97K.
Companies traded
Other insiders at CDLX
Insider Buying
$129K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Evans David Thomas made?
Evans David Thomas has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Evans David Thomas trade?
Evans David Thomas has filed SEC Form 4 disclosures for 1 company, including CDLX.
When was Evans David Thomas's most recent SEC Form 4 filing?
Evans David Thomas's most recent SEC Form 4 filing on Tracefour is dated May 19, 2026.
What is Evans David Thomas's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Evans David Thomas is listed as Chief Financial Officer.
What is Evans David Thomas's total buy and sell value in the current window?
Inside the rolling retention window, Evans David Thomas bought $129K and sold $0 based on SEC Form 4 filings.
What was Evans David Thomas's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 150,000 CDLX shares on 2026-05-15, worth $97K, per SEC Form 4 filings.